Houston Oncology Summit: How the Cancer Focus Fund Can Help Small Biotechs Get Into Phase 1 Studies (Video) by rpadmin | Sep 21, 2023 | Uncategorized
ImmunoGenesis and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Trial of IMGS-001 for Relapsed or Refractory Advanced Solid Tumors by rpadmin | Aug 31, 2023 | ImmunoGenesis
Ovarian Cancer Survivor: Immunotherapy Clinical Trial Saved by rpadmin | May 2, 2023 | Mereo BioPharma
ISA Pharmaceuticals And Cancer Focus Fund Announce $5 Million Investment To Support First- In-Human Trial Of ISA’s Novel Immunotherapy ISA103 In Uveal Melanoma by rpadmin | Jan 4, 2023 | ISA